Two crystal forms of complexes have been grown that contain human immunodeficiency virus type 1 reverse transcriptase and a monoclonal antibody Fab fragment. One of the crystal forms (form H, space group P3112, a = 168.7 A, c = 220.3 A) diffracts x-rays to 3.5-A resolution and appears suitable for moderate-resolution structure determination. The form H crystals have the unusual property that their maximum resolution of diffraction and resistance to radiation damage are enhanced by either crystallization in the presence of or soaking with double-stranded DNA primer-template mimics. These crystals may permit structural studies of cata-
= 168. 7 A, c = 220.3 A) diffracts x-rays to 3.5-A resolution and appears suitable for moderate-resolution structure determination. The form H crystals have the unusual property that their maximum resolution of diffraction and resistance to radiation damage are enhanced by either crystallization in the presence of or soaking with double-stranded DNA primer-template mimics. These crystals may permit structural studies of catalytically relevant complexes and eventually enable us to experimentally observe successive steps in the reverse transcription process.
AIDS, caused by the human immunodeficiency virus (HIV), is a fatal disease with no known cure. HIV reverse transcriptase (RT) is the target of the most widely used treatments for AIDS. Because RT is a polymerase, many of its inhibitors are nucleoside analogs, such as 3'-azido-3'-deoxythymidine (AZT) and dideoxynucleosides (e.g., dideoxyinosine and dideoxycytosine), that, when incorporated into the growing DNA chain, result in chain termination (reviewed in ref. 1) . However, some of the most potent and selective inhibitors of HIV-1 RT-for example, the recently reported diazepinone derivatives (2, 3)-are not nucleoside analogs and may inhibit by a different mechanism.
HIV-1 RT isolated from virions consists of a heterodimer containing two polypeptide chains of 66 and 51 kDa (p66 and p51) (4) . The two polypeptides have the same amino-terminal sequences. The p51 chain is produced by the cleavage of either the HIV-1 RT p66 or a larger precursor by the HIV-1 protease. When the p66 form of HIV-1 RT is expressed in Escherichia coli (5), a "bacterially processed" p66/pSi heterodimer can be prepared that has termini and catalytic properties similar to those of the enzyme found in virions. This heterodimer was used for the present work.
It is anticipated that a three-dimensional structure ofHIV-1 RT will accelerate the development of more effective agents for the treatment of AIDS. As methods for structure-based refinement of pharmaceutical agents improve, knowledge of the HIV-1 RT structure will become increasingly valuable. The structure of HIV-1 RT could be used both to search for new drugs and to guide the efficient improvement of existing inhibitors. There are problems with even the most successful of the available inhibitors of HIV-1 RT; for example, drugresistant viral mutants arise rapidly in patients treated with AZT (6) . A combination of inhibitors with varied targets on HIV-1 (7) is more likely to provide a successful treatment for AIDS than is any single agent.
Many laboratories have made extensive efforts to produce crystals of HIV-1 RT that are suitable for x-ray analysis (e.g., refs. [8] [9] [10] [11] [12] . There are no published reports of crystals that diffract to a resolution sufficient for a complete atomic description of the enzyme. We have used a variety of approaches to "engineer crystallizability," including protein engineering-aimed at changing the specific amino acids on the surface, making complexes with antibody fragments, or making complexes with synthetic nucleic acids that mimic primer-template substrates. In this paper, we describe conditions that allowed us to obtain crystals of HIV-1 RT p66/p5i heterodimer complexed with the antigen-binding fragment (Fab fragment) of a monoclonal antibody that diffract x-rays to 4-A resolution. We also demonstrate that these crystals can accommodate double-stranded DNA (ds-DNA) molecules of defined sequence. In the presence of nucleic acid, the resolution of the diffraction pattern increases to 3.5 A.
MATERIALS AND METHODS
Purification of HIV-1 RT p66/p5l Heteroduner. During the purification of HIV-1 RT p66/p66 homodimer from a bacterial expression system (13), Q-Sepharose fractions containing p66/p5i heterodimer were diafiltered into 20 mM Tris (pH 8 .0) and then loaded onto an HR 10/10 Mono Q anionexchange column (Pharmacia) previously equilibrated with 50 mM diethanolamine (pH 8.9). The column was developed with a linear gradient from 0 to 240 mM NaCl in the same buffer at 4 ml/min. The 108% Biochemistry: Jacobo-Molina et a!. In the cocrystallization experiments that included dsDNA oligomers, 1 u1d of a solution containing annealed oligomers at 1 nmol/pAl in 10 mM Tris, pH 7.5/100 mM NaCl/0.5 mM EDTA was added to 7-.lI hanging drops to give a 2-fold molar excess of DNA.
which had the highest affinity for the enzyme, was selected for cocrystallization with RT. Ascites fluid containing mAb28 was diluted 5-fold with 1.5 M glycine, pH 8.9/3 M NaCl and loaded at a flow rate of 5 ml/min onto a previously equilibrated 25-ml protein A-Sepharose column (Pharmacia). After extensive washing, the bound mAb was eluted with 100 mM sodium citrate (pH 3.0) into a tube containing 1 M Tris (pH 8.8). Purified mAb28 was diafiltered into 50 mM sodium acetate (pH 5.5) and stored at -80°C. Purified mAb28 was treated with papain crosslinked to agarose beads (Sigma) with shaking for 8 hr at 34°C. The resulting digest was filtered through a 0.22-pm Millex filter unit and then loaded onto an HR 10/10 Mono S cationexchange column (Pharmacia) equilibrated with 50 mM sodium acetate (pH 5.5). The flowthrough fraction containing Fab28 was diafiltered into 20 mM Tris, pH 8.0/25 mM NaCl and loaded onto an HR 10/10 Mono Q column equilibrated with 20 mM Tris (pH 8.0) and was eluted using a linear gradient from 75 to 85 mM NaCl in the same buffer. The major isoelectric form was collected and either used immediately for crystallization experiments or stored at -800C.
Preparation of Oligodeoxynucleotides. Oligonucleotides were synthesized in an Applied Biosystems DNA synthesizer (model 380B) using 1-,umol-scale columns. Three oligonucleotides (and their complements) were prepared: 5'-GGCGCCCGAACAGGGAC-3' 19-mer: 5'-ATGGCGCCCGAACAGGGAC-3' After purification by anion-exchange chromatography, complementary DNA strands were annealed in 10 mM Tris, pH 7.5/100 mM NaCl/0.5 mM EDTA by standard heating/ cooling protocols.
Complex Formation and Analysis. The appropriate mixing ratio of HIV-1 RT p66/pSi and Fab28 for complex formation was estimated using polyacrylamide gel electrophoresis under nondenaturing conditions. A 1 mg/ml solution of each protein was prepared using a Centricon-10 microconcentrator (Amicon). The Fab was mixed in a range of ratios with a constant amount of the p66/p5i heterodimer. These mixtures were run in a PhastSystem native PAGE (Pharmacia (17) reported the crystallization of a recombinant version of the HIV-1 gag CA p24 protein in a complex with an antibody Fab fragment. HIV-1 p24 has resisted all other attempts to form crystals, which may be due to a tendency of the protein to spontaneously aggregate to form capsid-like assemblies.
Diffraction Characteristics of the HIV-1 RT-Fab28 Form I Cocrystals. The HIV-1 RT p66/p51-Fab complex form I crystals (12) diffracted x-rays to 6-A resolution using the CHESS Fl beamline (A = 0.91 A) ( Table 2) . Crystals of a similar size gave poorer diffraction using either the CHESS Al station (A = 1.565 A) or an area detector/rotating anode combination (A = 1.54 A). The crystals used for both sets of experiments at CHESS grew in the same crystallization droplet; thus the difference in diffraction is not likely to be due to variations in the inherent crystal properties. The most likely explanation for the dramatic improvement in results with the Fl beamline is the increase in radiation stability of the RT-Fab complex crystals at shorter wavelengths.
Diffraction Characteristics of the HIV-1 RT-Fab28 Form II Cocrystals. The HIV-1 RT-Fab28 complex form II crystals grow as long blocks that often have threefold axial characteristics (Fig. 1) . Data have been measured from the form II crystals on an area detector and at CHESS using the Fl and Al beamlines ( Table 2 ). The description of the unit cell geometry and contents is given in Table 3 . The form II crystals have a number of characteristics that are suitable for structure determination. They are reasonably resistant to radiation damage, allowing collection of multiple successive exposures at a single position using synchrotron radiation at CHESS, or collection of a low-resolution (7 A) data set (with (I/W(I)) = 10) from a single crystal by using a rotating anode with an area detector. Crystal mosaicity is relatively low (00.2°), as evidenced from polychromatic (Laue) data collection at the CHESS B2 beamline, processing of synchrotron oscillation films, and examination of reflection profiles measured on an area detector.
Improved tDensity of the non-DNA-containing crystals was measured to be 1.16 g/cm3 (18) . This is consistent with the asymmetric unit containing two complexes each with one HIV-1 RT p66/p5i heterodimer, one Fab28, and one dsDNA oligonucleotide (when present). tCalculated by assuming a standard partial specific volume of 0.74 ml/g for the protein and for the DNA. §The data given in this entry correspond to a form II RT-Fab28 crystal that had been soaked with a solution containing the 15-bp dsDNA.
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absence of DNA. X-ray diffraction experiments were carried out using form II crystals with and without DNA ( Table 2 ). An x-ray diffraction photograph recorded from one of the form II-dsDNA (19 bp) cocrystals is shown in Fig. 2B . When compared with a photograph measured from a crystal of similar size of the form II crystals without DNA ( Fig. 2A) , using comparable conditions for oscillation range and exposure, the maximum diffraction resolution improved from 4.0 A for native crystals to 3.5 A for DNA-containing crystals. Diffuse scattering that can be seen in diffraction patterns obtained from form II native crystals ( Fig. 2A) is reduced in form II crystals containing DNA (Fig. 2B) . In addition, the DNA-containing crystals consistently showed greater resistance to radiation damage than the form II crystals without DNA, extending the usable diffraction lifetime by a factor of -2. All of the expected components, HIV-1 RT p66/p5i heterodimer, Fab28, and 19-bp dsDNA oligomers, are present in the crystals both before and after extensive rinsing (Fig. 3 ).
Soaking where 'hi corresponds to the ith observation of an intensity for reflection of index h whose average intensity is (In).
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The unit cell dimensions for form II crystals with and without DNA are quite similar (Table 3 ). The cell dimensions for crystals determined using both area-detector data and synchrotron film processing and post-refinement (form II native, heavy-atom derivatives, complexes with dsDNA) suggest that the structures with and without DNA are roughly isomorphous. Within eight area-detector data sets, there is a maximum variation of 1 A in the lengths of a and b and 0.6 A in c. Comparison of structure-factor amplitudes for data sets from DNA-and non-DNA-containing crystals indicates a change of 20o in the 25-to 8-A resolution range, vs. errors of 5-8% upon merging data from crystals of the same type. This magnitude of change is consistent with the presence of substantially ordered DNA. It may be possible to obtain an initial low-resolution set of phases by the isomorphous replacement method using the dsDNA addition as a "super-heavy atom."
The 12 complexes in the unit cell of the form II crystals are in a pseudohexagonal arrangement, as evidenced by lowresolution mirror symmetry perpendicular to cO. The selfrotation function of the form II crystals shows the highest non-origin peak at a value corresponding to a twofold rotation between the two complexes in the crystallographic asymmetric unit along the direction expected from the pseudohexagonal arrangement. Averaging of noncrystallographically equivalent copies of the RT polymerase domains and Fab28 combined with solvent flattening may facilitate phase determination and extension to high resolution (22) .
Implications for Future Studies and Possible Model for Structural Disorder of HIV-1 RT. Some of the difficulties in obtaining high-resolution crystals of HIV-1 RT may be due to the inherent properties of the enzyme. For example, HIV-1 RT may require a great deal of conformational flexibility to be able to processively polymerize a DNA strand from either an RNA or a DNA template. Since attempts to crystallize HIV-1 RT itself produced crystals with a low degree of order, it is possible that the surface ofthe enzyme is well ordered but that the molecule may be relatively flexible in regions that are most intimately involved in enzymatic activity. Another barrier to the formation of high-quality crystals of HIV-1 RT may be aggregation of the protein, particularly in the case of the p66/p66 homodimer. Aggregation of the p66/p66 homodimer may be due in part to the presence of a partially or fully unfolded RNase H domain (12, 23) .
The improved diffraction by the form II HIV-1 RT-Fab crystals in the presence of DNA may signify that part of the structural disorder is due to flexibility of the regions of the heterodimer that are in contact with nucleic acid substrates during polymerization. This concept is consistent with the existence of many crystal forms of HIV-1 RT, since the outer surface of the enzyme could still be well organized and participate in long-range lattice contacts. In addition to improved diffraction resolution, there is a significant reduction in the amount of diffuse scattering observed from the form II crystals when DNA is present. This result is also indicative of improved order in the form II crystals containing DNA, since diffuse scattering often connotes the presence of disordered fiber-like structures. The remarkable result that either cocrystallization or soaking with dsDNA oligomers improves the diffraction pattern suggests that these crystals may have special relevance for catalytic studies.
Note Added in Proof. In recent experiments at CHESS we have observed diffraction from the RT-Fab28-DNA form II crystals at 3.1-A resolution. We have also obtained a low-resolution structure of HIV-1 RT based on an electron density map computed using five heavy-atom derivative data sets at 7-A resolution.
